Michael Stott


UK & European Patent Attorney


Michael has worked in the patent profession since 2008 and prior to that he worked in the pharmaceutical industry. He has significant experience of drafting and prosecuting patent applications in the UK and Europe, as well as managing international patent portfolios and works with a wide range of clients including universities, SMEs and multinational corporations.

Michael has extensive experience of patent drafting, prosecution, global portfolio management, and freedom to operate and patent landscape assessments for clients in various technological fields, as well as experience of opposition and appeal proceedings before the European Patent Office (EPO). Michael works with a diverse array of clients, including multinational pharmaceutical companies, SMEs, universities, university spinouts, and startups.

Michael has a strong technical grounding in small molecule and medicinal chemistry, and particular technical expertise in the fields of pharmaceuticals and nutraceuticals, food technology, upstream and downstream oil and gas technologies, chemical processing and catalysis, ionic liquids, polymers, thin films and materials chemistry.

Michael has a first class master’s degree in chemistry from the University of York, and was awarded the university’s ‘ICI Prize’ for his performance in the final examinations. As part of his degree, Michael spent a year conducting research for a major pharmaceutical company and was involved in the development of intermediate and final stage compounds for a number of targets within respiratory and inflammatory therapeutic areas. After graduating, Michael continued working in the pharmaceutical industry, conducting research within the neurological therapeutic area with a particular focus on programs targeting the treatment of Alzheimer’s disease and migraine. He also holds a certificate in intellectual property law from Queen Mary, University of London, as well as an Intellectual Property (Basic) Litigation Certificate.

Michael is a fellow of the Chartered Institute of Patent Attorneys (CIPA).